Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCYBG Share News (CYBG)

Share Price Information for CYBG (CYBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.117
Bid: 17.016
Ask: 17.218
Change: -0.143 (-0.83%)
Spread: 0.202 (1.187%)
Open: 17.26
High: 0.00
Low: 0.00
Prev. Close: 17.26
CYBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CYBG surges on early Virgin Money progress, stronger margins

Wed, 06th Feb 2019 07:44

(Sharecast News) - CYBG reported "good progress" with the integration of Virgin Money since completing the merger in October, with lending up and margins stronger than expected despite pressure from the highly competitive UK mortgage market.Boosted by a strong pipeline coming into the first quarter of its financial year and good customer retention, group mortgage lending increased 1.5% to £60bn, helping group lending grow 1.4% to £71.9bn.Lending to small and medium-sized business grew 1.2% to £7.6bn.Annualised net interest margin, the key measure of a bank's margin between interest earned on money lent and paid on money saved, fell 20 basis points to 1.72% "due to sustained pricing pressure in the UK mortgage market". For the full year, NIM guidance was tightened up to between 1.65% and 1.70%, from the previous 1.60-1.70%Capital levels remained healthy with a CET1 ratio of 14.5%, down 60bps due to dividend payments and distributions for Virgin's Luxembourg-traded AT1s, but well above minimum regulatory requirements of 11.6%.The integration programme of Virgin Money since the deal was completed on 15 October has made "encouraging progress" on the initial stages of the three-year plan, with good progress on cost reductions so that initial milestones have been ticked off of underlying cost-to-income ratio in the first quarter below 60% and guidance increased to a minimum £150m of annual net run-rate cost synergies by the end of the 2021 financial year, versus £120m previously.Chief executive David Duffy said mortgage lending growth for the full year will be lower as "market dynamics remain consistent with those experienced over the last 12 months and pricing in that market remains highly competitive", leading CYBG to focus on optimising "volume and value".He was much more encouraged by the performance in SME, saying the bank was "well prepared for the start of the RBS Incentivised Switching Scheme and we hope to attract a large proportion of the 120,000 SME customers that RBS are required to switch", with an application submitted for a grant from the RBS Capability and Innovation Fund, "where we believe we offer the strongest case for delivering a genuine boost to competition in the SME market".Complaints about historic PPI modelling were around 1,800 per week, in line with current provisions.Shares in CYBG, having lost 50% of their value since August, soared 13% to 202.8p in early trading on Wednesday.Analysts at Shore Capital, which has a 'buy' rating on the shares, said loan growth was tracking slightly better than forecast, with NIM guidance narrowed to top half of previous range and versus a consensus forecast of 166bps and impairments running at 22bps - broadly in line with consensus at 21bps.The proforma core tier 1 ratio reduced by 60bps to 14.5% but "comfortably above" required levels and "implies circa £700m of surplus capital before management buffers are accounted for", versus a market cap of £2.6bn."On balance, we think this is a decent update which could drive modest upgrades to consensus, albeit maybe not so much for us given we are already top of the range. We therefore expect the shares to have a bounce following recent weakness."Broker Panmure Gordon said that, while it has previously regarded CYBG as having similar challenges as the larger UK banks with "low returns, bloated cost base, legacy conduct costs, the expected cost synergies from the merger will significantly improve profitability despite our concerns regarding margin pressure at Virgin Money".Moreover, the enlarged group will be "significantly overcapitalised" following the improvement in Virgin Money's CET1 ratio following PRA approvals for mortgage RWA models in July 2018 and accreditation of IRB models for CYBG from FY2019.Panmure estimate CYBG's pro-forma 2021 return on tangible equity will improve to 11.6%, driven by the analysts' assumption that £100m of the £120m cost synergies identified by management will be recognised in that year.
More News
26 Oct 2016 09:12

Banks' mortgage approvals rebound from low, BBA data shows

(ShareCast News) - Mortgage approvals from high street banks rebounded slightly in September, according to data from high street banks, after hitting a 19-month low in August. The British Bankers' Association (BBA) revealed mortgage approval numbers in September of 38,252, which was up from 37,241 i

Read more
26 Oct 2016 08:20

CYBG confirms talks with RBS over Williams & Glyn branches

(ShareCast News) - CYBG, the parent company of Clydesdale and Yorkshire Bank, confirmed that it has proposed a bid for 300 branches under the Williams & Glyn brand from Royal Bank of Scotland. Following reports late on Tuesday, CYBG said in a statement on Wednesday morning that it "has engaged in

Read more
26 Oct 2016 06:09

TOP NEWS: CYBG Confirms Bid Made For RBS's Williams & Glyn Arm

Read more
25 Oct 2016 15:59

Clydesdale launches offer for RBS's William & Glyn branches, report says

(ShareCast News) - Clydesdale & Yorkshire Bank parent CYBG has made an offer to buy the 300 Williams & Glyn branches from Royal Bank of Scotland, according to reports. CYBG, which has been rumoured to have begun working on the deal since August, has submitted a formal bid to buy the branches from RB

Read more
25 Oct 2016 11:46

Credit Suisse sees rising risks for challengers banks Aldermore, Shawbrook

(ShareCast News) - OneSavings Bank received an upgrade but Aldermore and Shawbrook were downgraded by Credit Suisse as it warned the risks facing the UK's challenger banks were "becoming harder to ignore" heading into 2017. Following solid share price recoveries in recent months, the risk-reward for

Read more
27 Sep 2016 09:33

WINNERS & LOSERS SUMMARY: Wolseley Sold Amid Job Cuts, No Extra Payout

Read more
21 Sep 2016 07:53

Santander pulls out of Williams & Glyn branch deal with RBS

(ShareCast News) - The Royal Bank of Scotland (RBS) has experienced a further setback in attempting to sell 315 high street branches as Santander pulled out of talks. Santander withdrew from the bid, two people briefed on the process the Financial Times, with one person having pointed to disagreemen

Read more
14 Sep 2016 08:37

Wednesday broker round-up

(ShareCast News) - Relx: Berenberg reiterates buy with a target price of 1600p. Standard Life: Deutsche Bank reiterates buy, 325p target. Arrow Globalik: Jefferies keeps at buy with a 359p target. Ocado: Exane BNP Paribas downgrades to underperform with a 215p target. SafeCharge: Berenberg stays

Read more
13 Sep 2016 07:38

CYBG ups medium-term financial guidance

(ShareCast News) - CYBG, the holding company of the Clydesdale and Yorkshire Bank, has hit its targets for the first year since flotation and upped its guidance for loan growth and cost-cutting for the next three years. The FTSE 250 bank said it expects the promised double-digit return on tangible e

Read more
12 Sep 2016 09:24

Monday broker round-up

(ShareCast News) - Autotrader: Barclays reiterates equal-weight with a target price of 375p. Hikma: Jefferies maintains buy with a 2500p target. Wood Group: Exane BNP Paribas upgrades to buy with a 815p target. Man Group: Citigroup upgrades to buy with a 137p target. McCarthy & Stone: Goldman Sac

Read more
30 Jun 2016 15:12

BROKER RATINGS SUMMARY UPDATE: Morgan Stanley Ups Schroders, Cuts RBS

Read more
29 Jun 2016 17:24

DIRECTOR DEALINGS: CYBG Director Fergus Murphy Increases Stake

Read more
29 Jun 2016 08:48

BROKER RATINGS SUMMARY: Merrill Lynch Upgrades Burberry To Buy

Read more
2 Jun 2016 08:00

FTSE quarterly review confirms raft of changes to 100 and 250 indices

(ShareCast News) - Hikma Pharmaceuticals' promotion to the FTSE 100 index was confirmed after the latest quarterly review was announced overnight, while demoted blue chip Inmarsat was joined in the FTSE 250 by three recently floated finance groups CYBG, CMC Markets and Metro Bank plus several others

Read more
1 Jun 2016 16:14

Hikma Pharmaceuticals Rejoins FTSE 100, Smurfit Kappa Joins FTSE 250

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.